{
    "clinical_study": {
        "@rank": "131222", 
        "arm_group": [
            {
                "arm_group_label": "SCu300A IUB", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "T380A copper IUD", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The SCu300A IUB\u2122 (hereafter IUB\u2122) will be evaluated for safety and effectiveness in\n      comparison with a market approved standard T shaped IUD containing 380sq.mm. of copper:\n\n      Comparison of objective parameters - Pregnancy rate, perforation, expulsion and malposition\n      rates, changes in the endometrial thickness, rate of complications such as infection and\n      anemia and discontinuation rates after 1 year.\n\n      Comparison of Subjective parameters - pain during insertion, menstrual characteristics and\n      pain, bleeding in correlation to the bleeding pattern prior to insertion.\n\n      Physician opinion: ease of use in insertion and removal. Subject satisfaction.\n\n      It is expected that subjects using the copper IUB will demonstrate less safety events, equal\n      effectiveness and equal or improved menstrual bleeding and pain related profiles compared\n      with users of the T shaped copper IUD."
        }, 
        "brief_title": "Multivariate Assessment of the IUB Intrauterine Device Compared With a T380A IUD", 
        "condition": "Prevention of Pregnancy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          -  Adult females aged 25-42\n\n          -  Free and willing to fully comply with treatment process\n\n          -  Healthy women seeking LARC\n\n          -  Married or in a steady relationship (at least 1 year)\n\n          -  Blood hemoglobin >11.5gr%\n\n          -  Signed informed consent form\n\n          -  If took COCP at least had one cycle after use of OC\n\n        Exclusion criteria:\n\n          -  Use IUB/IUD as an  emergency contraception\n\n          -  A previously placed IUD that has not been removed\n\n          -  Pregnancy or suspicion of pregnancy\n\n          -  Use of other contraception method (condom for either male or female, oral\n             contraceptives, diaphragms, spermicides, hormonal patches, injections or ring,\n             cervical cap)\n\n          -  History of pelvic inflammatory disease, recent or remote.\n\n          -  Postpartum endometritis or postabortal endometritis in the past 3 month\n\n          -  Mucupurulent cervicitis\n\n          -  Endometrial thickness more than 12 mm on insertion date\n\n          -  Known anemia (except thalassemia, sickle cell, chronic anemia)\n\n          -  History of previous IUD complications\n\n          -  Dysfunctional uterine bleeding\n\n          -  Undiagnosed uterine bleeding\n\n          -  Malignancy or suspected malignant disease of female inner or outer genitalia\n\n          -  Distortions of the uterine cavity by uterine fibroids or known anatomical\n             abnormalities\n\n          -  Known intolerance or allergy to nitinol or copper and/or copper IUDs - Wilson's\n             disease.\n\n          -  Medication that may interfere with the subject's ability to complete the protocol\n\n          -  Use of injectable contraception in the previous year\n\n          -  Any other significant disease or condition that could interfere with the subject's\n             ability to complete the protocol\n\n          -  A history of alcohol or drug abuse\n\n          -  Known infection with human immunodeficiency virus (HIV), Hepatitis B or Hepatitis C\n\n          -  Pregnancy or pregnancy planned during the year\n\n          -  Enrollment (less than 30 days after completing another study) in or planned to be\n             enrolled in another study"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "42 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "330", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02036177", 
            "org_study_id": "AOS-2000-04"
        }, 
        "intervention": [
            {
                "arm_group_label": "SCu300A IUB", 
                "description": "Spherical copper IUD", 
                "intervention_name": "SCu300A IUB intrauterine device", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "T380A copper IUD", 
                "description": "T-shaped copper IUD", 
                "intervention_name": "T380A IUD", 
                "intervention_type": "Device"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Copper"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 12, 2014", 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Randomized, Single Blind, Two Arm Controlled Study of the Safety and Efficacy of the SCu300A IUB\u2122 Spherical Copper Intrauterine Ball in Comparison to TCu 380 IUD Intra-uterine Contraceptive Device", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "Romania: Ministry of Health", 
                "Bulgaria: Ministry of Health"
            ]
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Number of uterine perforations during insertion", 
                "safety_issue": "Yes", 
                "time_frame": "At insertion visit"
            }, 
            {
                "description": "Number of women who experience partial or full device expulsion or device malposition during the trial period.", 
                "measure": "Expulsion and malposition rates", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Recording of the number of women who become pregnant during the trial period.", 
                "measure": "Efficacy in preventing pregnancy", 
                "safety_issue": "Yes", 
                "time_frame": "12 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02036177"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Recording of menstrual cramping, pain and bleeding irregularities during the trial period as reported by subjects.", 
            "measure": "Dysmenorrhea and menorrhagia severity", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "source": "Ocon Medical Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ocon Medical Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}